Efficacy and Safety of PLACENTEX ® i.m. in Patients With Scleroderma Diseases
Clinical trial NCT03388255 · TERMINATED
Trial details
- NCT number
- NCT03388255
- Sponsor
- Mastelli S.r.l
- Status
- TERMINATED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2016-11-08
- Primary completion
- 2019-10-30
- Enrollment
- 25
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.